The Food and Drug Administration (FDA, for its acronym in English) warned weeks ago that antibody tests can play an essential role in identifying people who were exposed to the SARS-CoV-2, causing the disease covid-19.
In addition, for those who developed a adaptive immune response. However, the body does not advise its use to determine immunity or protection against this pathology, after the application of the vaccine against him covid-19.
On Ecuador -and in several Latin American countries- these exams are offered to know if the person is protected or not.
THE COMMERCE spoke with Jhommara Bautista, an expert in biotechnology, this Monday, August 23, 2021.
She explained that the goal of those tests is qualify the immune response and also to see the capacity of these for to block the union of the protein ‘S’ -Known as ‘Spike’ or spike-.
“It is not necessary for people to do it. We are not in clinical trials to see if they work; the vaccines have already been approved and have gone through rigorous testing. They all work, they all protect us; without exception. These tests are not standardized ”.
In addition, he commented that the effectiveness of the vaccines it is not reduced to production from antibodies, the goal T that provide good protection.
–
